[go: up one dir, main page]

MX2013000502A - Metodos y kits para el diagnostico de cancer de prostata. - Google Patents

Metodos y kits para el diagnostico de cancer de prostata.

Info

Publication number
MX2013000502A
MX2013000502A MX2013000502A MX2013000502A MX2013000502A MX 2013000502 A MX2013000502 A MX 2013000502A MX 2013000502 A MX2013000502 A MX 2013000502A MX 2013000502 A MX2013000502 A MX 2013000502A MX 2013000502 A MX2013000502 A MX 2013000502A
Authority
MX
Mexico
Prior art keywords
methods
prostate cancer
subject
kits
diagnosis
Prior art date
Application number
MX2013000502A
Other languages
English (en)
Inventor
Andreas Doll
Marina Rigau Resina
Juan Morote Robles
Miguel Abal Posada
Jaume Reventos Puigjaner
Original Assignee
Fundacio Inst De Recerca Hospital Uni Vall D Hebron Fundacio Privada
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Fundacio Inst De Recerca Hospital Uni Vall D Hebron Fundacio Privada filed Critical Fundacio Inst De Recerca Hospital Uni Vall D Hebron Fundacio Privada
Publication of MX2013000502A publication Critical patent/MX2013000502A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/118—Prognosis of disease development
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/158—Expression markers
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/16—Primer sets for multiplex assays

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Pathology (AREA)
  • Analytical Chemistry (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Hospice & Palliative Care (AREA)
  • Biophysics (AREA)
  • Oncology (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)

Abstract

La invención se refiere a métodos y kits para el diagnóstico de cáncer de próstata en un sujeto, para evaluar o seguir la respuesta a una terapia en un sujeto que tiene cáncer de próstata (CaP) o para seguir la evolución del cáncer de próstata (CaP) basados en la detección de cambios en los niveles de expresión de al menos un gen seleccionado del grupo de PCA3, PSMA y PSGR. La invención se refiere asimismo a métodos para evaluar si un sujeto se tiene que someter a una biopsia de próstata, dicho sujeto tiene PSA en suero en el intervalo 4-10 ng/mL.
MX2013000502A 2010-07-14 2011-07-14 Metodos y kits para el diagnostico de cancer de prostata. MX2013000502A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP10382194A EP2407555A1 (en) 2010-07-14 2010-07-14 Methods and kits for the diagnosis of prostate cancer
PCT/EP2011/062049 WO2012007545A1 (en) 2010-07-14 2011-07-14 Methods and kits for the diagnosis of prostate cancer

Publications (1)

Publication Number Publication Date
MX2013000502A true MX2013000502A (es) 2013-05-14

Family

ID=42711863

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2013000502A MX2013000502A (es) 2010-07-14 2011-07-14 Metodos y kits para el diagnostico de cancer de prostata.

Country Status (11)

Country Link
US (1) US20130178393A1 (es)
EP (2) EP2407555A1 (es)
JP (1) JP2013531997A (es)
CN (1) CN103221553A (es)
AU (1) AU2011278285A1 (es)
BR (1) BR112013000869A2 (es)
CA (1) CA2805353A1 (es)
MX (1) MX2013000502A (es)
RU (1) RU2013106420A (es)
TW (1) TW201217786A (es)
WO (1) WO2012007545A1 (es)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20130203615A1 (en) * 2011-08-05 2013-08-08 Gen-Probe Incorporated Antiandrogen therapy monitoring methods and compositions
CN104878077A (zh) * 2014-02-28 2015-09-02 谭巍 PCA3 mRNA/ACPP mRNA RT-PCR检测引物及检测试剂盒
AU2015230017B2 (en) * 2014-03-11 2021-06-17 A3P Biomedical Ab Method for detecting a solid tumor cancer
CN104531852A (zh) * 2014-12-12 2015-04-22 广东省妇幼保健院 一种锁核酸增敏的检测mthfr基因c677t突变的探针及引物、试剂盒和检测方法
CN104531862B (zh) * 2014-12-19 2017-12-29 钱学庆 检测人类brca1和brca2基因全外显子序列突变位点的方法和引物
CN104531863A (zh) * 2014-12-19 2015-04-22 钱学庆 一种人类尿液中pca3基因检测方法和引物
CN106399509A (zh) * 2016-09-23 2017-02-15 北京致成生物医学科技有限公司 一种诊断前列腺癌的产品及其应用
CN110431241B (zh) * 2017-02-28 2024-04-19 梅约医学教育与研究基金会 检测前列腺癌
CN107907684A (zh) * 2017-09-29 2018-04-13 何皓 一种基于多重荧光寿命分辨检测技术的前列腺癌早期诊断系统
US11530451B2 (en) 2018-03-02 2022-12-20 The Johns Hopkins University Methods for prostate cancer detection
WO2020071199A1 (ja) * 2018-10-04 2020-04-09 コニカミノルタ株式会社 補助情報の取得方法
CN109762905A (zh) * 2019-03-11 2019-05-17 天津脉络医学检验有限公司 一种用于辅助检测前列腺癌的ddPCR引物组合物及其应用
CN110423797A (zh) * 2019-07-11 2019-11-08 杨海涛 一种前列腺癌pca3基因双重实时pcr的引物、方法及试剂盒
CN111394455A (zh) * 2020-03-09 2020-07-10 皖南医学院 一种检测前列腺癌的试剂盒及其制备方法
CN114410787A (zh) * 2022-01-24 2022-04-29 上海康黎医学检验所有限公司 一种用于前列腺癌早期诊断、转移预警以及预后评估的引物探针组合、试剂盒及其应用

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5935860A (en) 1995-03-07 1999-08-10 The George Washington University Use of uteroglobin expression as a molecular marker for prostatic intraepithelial neoplasia
AU722819B2 (en) 1996-12-06 2000-08-10 Urocor, Inc. Diagnosis of disease state using mRNA profiles
AU7019498A (en) 1997-04-10 1998-10-30 Diagnocure Inc. Pca3, pca3 genes, and methods of use
JP2003531356A (ja) 1999-06-29 2003-10-21 マクギル ユニバーシティー プリオンタンパク質結合タンパク質及びそれらの使用
WO2002081656A2 (en) * 2001-04-05 2002-10-17 The Henry M. Jackson Foundation Enhanced diagnostic potential of prostate-specific antigen expressing cells
AU2002337657A1 (en) * 2001-07-25 2003-02-17 Millennium Pharmaceuticals, Inc. Novel genes, compositions, kits, and methods for identification, assessment, prevention, and therapy of prostate cancer
US20040241707A1 (en) * 2002-04-01 2004-12-02 Gao Chun L. Enhanced diagnostic potential of prostate-specific antigen expressing cells
US20050282170A1 (en) 2003-02-07 2005-12-22 Diagnocure Inc. Method to detect prostate cancer in a sample
CA2432365A1 (en) 2003-06-30 2004-12-30 Jack A. Schalken Specific method of prostate cancer detection based on pca3, and kits therefore
DE102006032394B4 (de) 2006-03-17 2011-07-07 Technische Universität Dresden, 01069 Verfahren zur Diagnose und Differenzierung von Prostatakrebs
AU2007350331A1 (en) 2007-03-30 2008-10-09 Source Precision Medicine, Inc. D/B/A Source Mdx Gene expression profiling for identification, monitoring, and treatment of prostate cancer
WO2009135019A2 (en) 2008-05-01 2009-11-05 Beth Israel Deaconess Medical Center Methods and compositions for prostate cancer immunotherapy

Also Published As

Publication number Publication date
CN103221553A (zh) 2013-07-24
TW201217786A (en) 2012-05-01
EP2407555A1 (en) 2012-01-18
BR112013000869A2 (pt) 2016-05-17
RU2013106420A (ru) 2014-08-20
WO2012007545A1 (en) 2012-01-19
EP2593562A1 (en) 2013-05-22
AU2011278285A1 (en) 2013-02-07
JP2013531997A (ja) 2013-08-15
US20130178393A1 (en) 2013-07-11
CA2805353A1 (en) 2012-01-19

Similar Documents

Publication Publication Date Title
MX2013000502A (es) Metodos y kits para el diagnostico de cancer de prostata.
EP4219765A3 (en) Prostate cancer prognosis using biomarkers
EP2611941A4 (en) GENESIS OF CANCER DIAGNOSIS AND PROGNOSIS
WO2009115615A3 (en) Detection and prognosis of cervical cancer
EP2663656A1 (en) Genetic variants as markers for use in urinary bladder cancer risk assessment, diagnosis, prognosis and treatment
MX2013000917A (es) Metodos para detectar las enfermedades o condiciones usando celulas fagociticas.
WO2010009337A3 (en) Signatures and pcdeterminants associated with prostate cancer and methods of use thereof
WO2008097908A3 (en) Methods of diagnosing and prognosing lung cancer
WO2009037572A3 (en) Biomarker combinations for colorectal cancer
WO2011047033A3 (en) Biomarker for identification of melanoma tumor cells
WO2010004591A3 (en) Genetic variants for breast cancer risk assessment
WO2011015944A3 (en) Use of free dna as an early predictor of severity in acute pancreatitis
HK1197085A1 (en) Genetic variants for predicting risk of breast cancer
MX382244B (es) Metodos para detectar firmas de enfermedad o condiciones en fluidos corporales
WO2011153254A3 (en) Prostate cancer associated circulating nucleic acid biomarkers
WO2012177945A3 (en) Diagnostic methods for eosinophilic esophagitis
WO2011088149A3 (en) Methods for predicting response of triple-negative breast cancer to therapy
WO2015094995A3 (en) Gene signature biomarkers of tumor response to pd-1 antagonists
WO2010120942A3 (en) Histone modification patterns for clinical diagnosis and prognosis of cancer
EP2527466A3 (en) Genetic variants on CHR2 as markers for use in breast cancer risk assessment, diagnosis, prognosis and treatment
EP3385717A3 (en) Methods of detecting prostate cancer
WO2013043878A3 (en) Alternative splicing variants of genes associated with prostate cancer risk and survival
WO2013057581A8 (en) Composite biomarker for non-invasive screening, diagnosis and prognosis of colorectal cancer
WO2009149319A3 (en) Gene expression profiles associated with asthma exacerbation attacks
MX358474B (es) Biomarcadores salivales específicos para detección de riesgo, diagnóstico temprano, pronóstico y vigilancia de las enfermedades de alzheimer y de parkinson.